Hepatitis C virus infection in liver allograft recipients

L Caccamo1, M Colledan, B Gridelli

  • 1Istituto di Chirurgia Sperimentale e dei Trapianti Centro Trapianto Fegato, Università di Milano, Ospedale Maggiore I.R.C.C.S., Italy.

Insights

Hepatitis C Virus (HCV) infection significantly impacts liver transplant outcomes. Pre-transplant HCV infection in recipients leads to high recurrence rates, emphasizing the need for careful donor-recipient screening.

Area of Science:

  • Hepatology
  • Transplantation Immunology
  • Virology

Background:

  • Hepatitis C Virus (HCV) infection poses challenges in liver transplantation.
  • Understanding HCV transmission dynamics and post-transplant outcomes is crucial for patient management.

Purpose of the Study:

  • To determine the prevalence of anti-HCV antibodies in liver donors.
  • To assess the risk of HCV infection and re-infection in recipients based on pre-transplant anti-HCV status.
  • To evaluate the prevalence of HCV in post-transplant chronic hepatitis.

Main Methods:

  • Sera from 42 liver transplant recipients and their donors were tested for anti-HCV antibodies.
  • Patients were categorized based on pre-transplant donor (D) and recipient (R) anti-HCV status (D-/R-, D-/R+, D+/R-, D+/R+).
  • Liver biopsies were performed on 21 patients with sustained hepatic dysfunction.

Main Results:

  • The prevalence of anti-HCV positivity in liver donors was low (3.2%).
  • Acquired HCV infection occurred in 9.7% of recipients in the D-/R- group.
  • Recurrent HCV hepatitis was high (44.4%) in the D-/R+ group, with 2 deaths due to liver failure.
  • HCV was the primary cause of post-transplant chronic hepatitis (77.8%).

Conclusions:

  • Pre-transplant HCV infection in recipients is associated with a high incidence of recurrence after liver transplantation.
  • HCV remains a significant etiological factor in chronic hepatitis post-liver transplant.
  • Careful donor-recipient screening for anti-HCV status is essential to minimize transmission and recurrence.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...